Canadian Agency for Drugs and Technologies in Health
$20,597,323.00 CAD
- Department
- Health Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- March 28, 2022 – March 31, 2025
- Reference
- hc-sc:271-2023-2024-Q4-00077
Published purpose
To enhance the health of Canadians and health system sustainability by promoting the cost-effective and optimal use of drugs and other health technologies.
In plain English AI-generated
This contribution supports the Canadian Agency for Drugs and Technologies in Health to promote cost-effective and optimal use of drugs and health technologies, aiming to improve health outcomes and sustainability of Canada's health system.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.